Which antiepileptic is recommended for seizures secondary to brain metastases, taking into account drug‑drug interactions with chemotherapy?

Levetiracetam is the Recommended First-Line Antiepileptic for Seizures Due to Brain Metastases

Levetiracetam should be initiated as first-line therapy for patients with brain metastases who experience a seizure, primarily because it lacks significant drug-drug interactions with chemotherapy agents and has favorable efficacy and tolerability. 1

Key Recommendation Framework

When to Start Antiepileptic Therapy

• Start antiepileptic drugs ONLY after a documented seizure has occurred - prophylactic use in seizure-free patients is not recommended and has been shown ineffective 1, 2, 3
• Patients who experience even a single seizure should receive secondary prophylaxis, at least temporarily 1

First-Line Agent: Levetiracetam

The 2021 EANO-ESMO guidelines explicitly state that levetiracetam and lamotrigine are preferred first-choice options due to efficacy and overall good tolerability 1. Among these, levetiracetam has become the drug of first choice at most neuro-oncology centers 1.

Why levetiracetam is preferred:

• No cytochrome P450 enzyme interactions - does not alter metabolism of chemotherapy agents, targeted therapies, or corticosteroids 4, 5, 6
• Immediate therapeutic levels achievable (unlike lamotrigine which requires weeks of titration) 1
• Well-tolerated with comparable efficacy to older agents 4
• No hematologic toxicity concerns 4

Critical Drug Interactions to Avoid

Enzyme-inducing antiepileptics (phenytoin, phenobarbital, carbamazepine) should be avoided in patients with brain tumors 1. These agents:

• Significantly reduce serum concentrations of chemotherapy agents, potentially compromising antitumor activity 1, 7, 6
• Interact with corticosteroids and various cytotoxic and targeted agents 1
• Have unfavorable side-effect profiles 1

Alternative Options

If levetiracetam is not tolerated or ineffective:

Second-line monotherapy options:

• Lamotrigine - good antiseizure activity but requires several weeks to reach therapeutic levels 1
• Lacosamide - increasingly used as add-on therapy or alternative first-line 1, 5

Add-on therapy for refractory seizures:

• Lacosamide may assume a larger role for patients not controlled on monotherapy 1
• Valproic acid can be considered but requires caution 1

Important Caveats with Valproic Acid

While valproic acid maintains efficacy and is still used at some centers 1:

• Must not be used in females of childbearing potential 1
• Associated with higher hematologic toxicities when combined with chemotherapy 4
• Potential for thrombocytopenia and hepatotoxicity 4
• Drug interactions require regular monitoring 1

Common Pitfall: Psychiatric Side Effects

Monitor for psychiatric adverse effects with levetiracetam - mood changes, irritability, and behavioral issues can occur in some patients 1, 5. If the patient has pre-existing psychiatric comorbidities, consider alternative agents like lacosamide or lamotrigine as first-line 5.

Duration of Therapy

Continue antiepileptic therapy until local tumor control is achieved 1. If near-gross total resection is accomplished, consider tapering within weeks after surgery if no recurrent tumor growth occurs 1.

Monitoring

• Assess seizure occurrence at each follow-up visit 1
• Serum drug levels can be checked to assess compliance and evaluate treatment failure 1
• Worsening seizure control often heralds tumor progression - consider repeat imaging 1